Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway

Caveolin 1:PP2A/ATM/p53 通路的新型调节剂

基本信息

项目摘要

DESCRIPTION (provided by applicant): One of the manifestations of aging is the accumulation of damage at both cellular and organism levels. Genotoxic stress plays an important role in aging and age-related diseases such as emphysema, which is caused by a failure of lung maintenance and repair after sustained oxidative stress. Cigarette smoke represents a source of oxidants and is considered an environmental hazard that causes pulmonary emphysema. Premature senescence is believed to contribute to genotoxic stress-induced emphysema. The tumor suppressor protein p53 is a key regulator of premature senescence and is activated by the ataxia-telangiectasia mutated (ATM) protein kinase when the ATM inhibitor protein phosphatase 2A (PP2A) dissociates from ATM after genotoxic stress. The mechanism underlying PP2A-C removal from ATM upon genotoxic stress remains totally unexplored. In addition, the role that the ATM/p53 pathway plays in cigarette smoke-induced cellular senescence and the pathogenesis of emphysema remains largely unknown. Here, we plan to test the hypothesis that the lipid raft protein caveolin-1 mediates stress-induced premature senescence by promoting ATM-dependent activation of p53 through sequestration of the ATM inhibitor PP2A-C into caveolae. In addition, it is hypothesized that caveolin-1 plays a central role in oxidant-promoted emphysema in vivo through induction of cellular senescence. This hypothesis will be tested by pursuing three specific aims: Specific Aim 1: Investigate the role of caveolin-1 in PP2A-mediated regulation of ATM function after genotoxic stress. Specific Aim 2: Determine the functional consequences of loss of caveolin-1 expression on ATM-mediated p53 activation and premature senescence. Specific Aim 3: Define the role of caveolin-1 in genotoxic stress-induced pulmonary emphysema in vivo. These studies will provide novel insights into the signaling machinery that links genotoxic stress to cellular senescence and propose caveolin-1 as a novel therapeutic target for the treatment of age-related diseases such as emphysema. PUBLIC HEALTH RELEVANCE: Oxidative stress, including cigarette smoke, promotes premature cellular senescence, which is believed to have an important role in the more complicated aging process, and contributes to age-related diseases like emphysema. The molecular mechanisms underlying cigarette smoke-induced emphysema are not fully understood. Our studies will test the hypothesis that the protein caveolin-1 is a novel regulator of stress-induced cellular senescence and emphysema, and propose caveolin-1 as an alternative therapeutic target for the treatment of age-related diseases such as emphysema.
描述(由申请人提供):衰老的表现之一是细胞和生物体水平的损伤累积。遗传毒性应激在衰老和与年龄相关的疾病如肺气肿中起着重要作用,肺气肿是由持续氧化应激后肺维持和修复失败引起的。香烟烟雾是氧化剂的来源,被认为是导致肺气肿的环境危害。过早衰老被认为有助于遗传毒性应激诱导的肺气肿。肿瘤抑制蛋白p53是早衰的关键调节因子,并且当遗传毒性应激后ATM抑制蛋白磷酸酶2A(PP 2A)从ATM解离时,由共济失调-毛细血管扩张突变(ATM)蛋白激酶激活。PP 2A-C在遗传毒性胁迫下从ATM中去除的潜在机制仍然完全未被探索。此外,ATM/p53通路在香烟烟雾诱导的细胞衰老和肺气肿的发病机制中所起的作用在很大程度上仍然未知。在这里,我们计划测试的假设,脂筏蛋白小窝蛋白-1介导的压力诱导的早衰,通过促进ATM依赖性激活p53通过螯合的ATM抑制剂PP 2A-C到小窝。此外,假设小窝蛋白-1通过诱导细胞衰老在体内氧化剂促进的肺气肿中起核心作用。这一假设将通过追求三个具体目标进行测试:具体目标1:研究基因毒性应激后小窝蛋白-1在PP 2A介导的ATM功能调节中的作用。具体目标2:确定小窝蛋白-1表达的丧失对ATM介导的p53激活和早衰的功能后果。具体目标3:确定小窝蛋白-1在体内遗传毒性应激诱导的肺气肿中的作用。这些研究将为将遗传毒性应激与细胞衰老联系起来的信号机制提供新的见解,并提出caveolin-1作为治疗年龄相关疾病(如肺气肿)的新治疗靶点。公共卫生关系:氧化应激,包括吸烟,促进细胞过早衰老,这被认为在更复杂的衰老过程中起重要作用,并导致与年龄相关的疾病,如肺气肿。香烟烟雾诱发肺气肿的分子机制尚未完全清楚。我们的研究将测试的假设,即蛋白质小窝蛋白-1是一种新的调节应激诱导的细胞衰老和肺气肿,并提出小窝蛋白-1作为一种替代的治疗目标,用于治疗与年龄有关的疾病,如肺气肿。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Caveolin-1 controls mitochondrial function through regulation of m-AAA mitochondrial protease.
  • DOI:
    10.18632/aging.101051
  • 发表时间:
    2016-10-04
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Volonte D;Liu Z;Shiva S;Galbiati F
  • 通讯作者:
    Galbiati F
Caveolin-1, cellular senescence and age-related diseases.
  • DOI:
    10.1016/j.mad.2011.11.001
  • 发表时间:
    2011-11
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Zou H;Stoppani E;Volonte D;Galbiati F
  • 通讯作者:
    Galbiati F
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FERRUCCIO GALBIATI其他文献

FERRUCCIO GALBIATI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FERRUCCIO GALBIATI', 18)}}的其他基金

Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9305499
  • 财政年份:
    2017
  • 资助金额:
    $ 27.47万
  • 项目类别:
Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9459856
  • 财政年份:
    2017
  • 资助金额:
    $ 27.47万
  • 项目类别:
Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9899946
  • 财政年份:
    2017
  • 资助金额:
    $ 27.47万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    9279206
  • 财政年份:
    2015
  • 资助金额:
    $ 27.47万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    9059176
  • 财政年份:
    2015
  • 资助金额:
    $ 27.47万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    8903586
  • 财政年份:
    2014
  • 资助金额:
    $ 27.47万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8114097
  • 财政年份:
    2009
  • 资助金额:
    $ 27.47万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8301580
  • 财政年份:
    2009
  • 资助金额:
    $ 27.47万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    7903303
  • 财政年份:
    2009
  • 资助金额:
    $ 27.47万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    7574065
  • 财政年份:
    2009
  • 资助金额:
    $ 27.47万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
  • 批准号:
    498278
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
  • 批准号:
    24K04938
  • 财政年份:
    2024
  • 资助金额:
    $ 27.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了